[Pilot application of optical in vivo imaging on acupuncture research].

OBJECTIVE: As a new technique of biomedical imaging, the optical in vivo imaging has been used in many research fields of biological processes, such as analyzing gene expression pattern, observing action of drug target. For extending its application field, this technique is initially used to investigate the effect of acupuncture in this study. METHODS: Seven SPF mice were randomly divided into an acupuncture group (4 cases) and a control group (3 cases). Fluorescent labeling Cy7 (Tf-Cy7) and Doxorubicin (Dox) were injected into the caudal vein of the nude mice, respectively. With the.stabilized distribution of Tf-Cy7 and Dox in vivo, "Yaoyangguan" (GV 3) point was acupunctured in the acupuncture group. The animals in the control group were not acupunctured. Then, the fluorescent irradiance of Tf-Cy7 and Dox was displayed by the optical in vivo imaging, the effect of acupuncture was analyzed. RESULTS: (1) After acupuncture, the fluorescent intensity of Tf-Cy7 started to decrease in the blood-brain barrier and heart, but tended to increase in the liver and spleen, in which the highest intensity of Tf-Cy7 was demonstrated at 50 min during the acupuncture. It was obviously different from that of the control group. (2) The fluorescent intensity of Dox tended to increase in the brain and lung after 20 min of acupuncture, and reached the highest concentration at 30 min. CONCLUSION: Acupuncture can influence the action of Tf-Cy7 targeting and distribution of Dox, which is clearly showed with the optical in vivo imaging. Thus, this technique provides a new approach for the acupuncture and meridian research.

A novel thioredoxin reductase inhibitor inhibits cell growth and induces apoptosis in HL-60 and K562 cells.

Human thioredoxin reductase (TrxR) system is associated with cancer cell growth and anti-apoptosis process. Effects of 1,2-[bis(1,2-benzisoselenazolone-3(2H)-ketone)]ethane (BBSKE), a novel TrxR inhibitor, were investigated on human leukemia cell lines HL-60 and K562. BBSKE treatment induced cell growth inhibition and apoptosis in both cell lines. Apoptosis induced by BBSKE is through Bcl-2/Bax and caspase-3 pathways. Ehrlich's ascites carcinoma-bearing mice were used to investigate the anti-tumor effect of BBSKE in vivo. Tumor-bearing mice treated with BBSKE showed an increase of life span with a comparable effect to cyclophosphamide (CTX). These results suggest a potential usage of BBSKE as a therapeutic agent against non-solid tumors.

[Realgar nano-particles induce apoptosis and necrosis in leukemia cell lines K562 and HL-60].

OBJECTIVE: To examine the growth-inhibitory, apoptosis- and necrosis-inducing effects of realgar nano-particles (RNP) in human chronic myelogenous leukemia cell line K562 and acute myeloid leukemia cell line HL-60, and to find out the chemical species with efficacy. METHOD: A "solvent-relay" strategy was used for the preparation of RNP suspension. Cell viability was determined by MTT assay. Cell apoptosis and necrosis were characterized with Annexin V-PI double staining in association with flow cytometry and with morphological examination with Hoechst 33258 staining. Parallel experiments with arsenous acid (H3AsO3), the dominant form of arsenic trioxide in the solution, were conducted for comparison. RESULT: The mean diameter of RNP was 159.0 nm. RNP showed growth-inhibitory effect on both cell lines. The double staining test indicated that RNP induced both apoptosis and necrosis, and this was further confirmed by morphological examination. CONCLUSION: RNP induced both apoptosis and necrosis in leukemia cell lines K562 and HL-60. Thioarsenite species with both As-O and As-S bonds may be the active intermediates in the RNP.